Cite
HARVARD Citation
Dunn, K. et al. (n.d.). 1015. Gastrointestinal (GI) Adverse Events With Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Through Week 96: An AMBER Post Hoc Analysis. Open forum infectious diseases. pp. S536-S537. [Online].